Is Naproxen Better Than Ibuprofen for Pain Relief?

Neither naproxen nor ibuprofen is categorically better for pain relief. At equivalent over-the-counter doses, the two drugs deliver similar levels of pain reduction for most conditions, with head-to-head trials typically showing no clinically meaningful gap in how much pain they eliminate. The practical differences lie elsewhere: naproxen lasts substantially longer per dose, the two drugs carry different cardiovascular and gastrointestinal risk profiles, and certain pain types respond slightly better to one or the other. Choosing between them is less about raw potency and more about matching the drug to your situation.

Similar Mechanism, Similar Potency

Both naproxen and ibuprofen belong to the same drug class and work by blocking the enzymes that produce prostaglandins, the chemicals your body releases in response to injury or inflammation. Those enzymes come in two forms, and both drugs inhibit both of them in a roughly nonselective way.¹ The result is that a dose of one drug does about the same work as an equivalent dose of the other. In practice, about 440 mg of naproxen sodium is roughly equivalent in pain-relieving strength to 400 mg of ibuprofen. If you compare them milligram-for-milligram, you are not comparing like with like, because their potencies per milligram differ slightly.

Where the two drugs do diverge at the enzyme level is in how strongly each blocks one form versus the other. In one study measuring actual enzyme inhibition in healthy volunteers, both drugs knocked out the inflammation-related enzyme by about 71%, but ibuprofen suppressed the other form by about 89% while naproxen suppressed it by about 95%.² That stronger suppression of the first enzyme form has implications for stomach protection and blood clotting, which matter more in the side-effect discussion than in pain relief itself.

The Duration Advantage

The most obvious everyday difference between these two drugs is how long a single dose works. Naproxen has a half-life of roughly 12 to 17 hours, meaning you take it twice a day at most. Ibuprofen’s half-life is closer to two hours, so you need a new dose every four to six hours to keep the effect going. For something like a tension headache that passes quickly, ibuprofen’s shorter action is not a drawback. But for ongoing pain from arthritis, a sports injury, or back trouble, having to re-dose three or four times a day becomes a nuisance and a risk factor for missed doses.

A review focused specifically on back pain noted that naproxen’s long half-life allows sustained, all-day pain relief with fewer pills, which can improve how consistently people actually take their medication.³ This matters particularly for older adults or anyone managing several medications at once, where adding three extra pill-taking moments to the day is a real barrier to staying on track.

How They Compare Across Pain Types

Joint and Muscle Pain

For osteoarthritis of the knee, one randomized trial of over 400 patients found that both drugs reduced pain by about 30 to 45% compared with a roughly 20 to 25% reduction from placebo. Naproxen improved all seven measured symptoms compared to placebo, while ibuprofen improved five of the seven, and naproxen showed a trend toward better overnight pain relief.⁴ A separate study in elderly knee osteoarthritis patients also found both drugs effective and well tolerated, with no meaningful difference in side effects between the groups.⁵

A crossover trial in general practice, where patients tried both drugs in sequence, found naproxen ahead on resting pain, movement pain, night pain, and interference with daily activities. Patients who started on ibuprofen and switched to naproxen improved further; those who started on naproxen and switched to ibuprofen did not. Overall preference favored naproxen.⁶ The likely explanation is duration: naproxen’s longer action provides more consistent overnight coverage, which is when joint stiffness and aching tend to be worst.

Dental Pain

Post-surgical dental pain is one of the most common models for testing painkillers, because the pain is predictable and peaks within hours. In this setting, naproxen and ibuprofen kick in at about the same speed, and for the first several hours they provide comparable relief. The separation shows up later. In a double-blind trial, naproxen trended toward better pain control from hours 1 through 12, reaching a statistically significant advantage at the 12-hour mark.⁷

A more recent randomized trial reinforced this pattern. Only about 35% of naproxen patients needed rescue medication over 24 hours, compared with 83% of ibuprofen patients and about 82% of those on placebo. The biggest gap between the two drugs appeared in the 9-to-14-hour window, and naproxen delivered greater total pain relief over the full 24-hour period.⁸ In short, if you have a tooth pulled and want to take one dose before bed without waking up in pain, naproxen is the better bet.

Menstrual Cramps

Period pain, or primary dysmenorrhea, is driven by prostaglandins, which makes it a natural target for both drugs. The evidence here tells a less one-sided story than the dental pain data. A network meta-analysis pooling multiple trials ranked ibuprofen as the second most effective over-the-counter option for menstrual cramps, behind diclofenac, while naproxen came in lower.⁹ Yet a pooled analysis of five individual studies found that naproxen at 400 mg provided greater pain relief than ibuprofen at the six-hour mark.¹⁰

How do you square these two findings? Timing and dosing likely explain the difference. Ibuprofen’s faster onset may deliver a stronger initial punch in the first couple of hours, which matters when cramps hit suddenly and sharply. Naproxen’s staying power means fewer re-doses over a long day of discomfort. If you are someone whose cramps flare intensely and then ease, ibuprofen may feel more effective. If your pain stretches across the better part of a day, naproxen’s longer coverage could be the better match.

Migraines

Both drugs have good evidence for treating acute migraine attacks in adults and are considered part of the core group of first-line treatments alongside triptans and acetaminophen.¹¹ Clinical guidelines do not rank one above the other for migraine specifically. In practice, many clinicians recommend ibuprofen for migraines because of its faster onset, reasoning that early, rapid treatment is important for stopping a migraine before it fully develops. Naproxen’s longer duration can be useful if your migraines tend to linger or recur later in the day.

The Heart Safety Question

This is where the two drugs diverge most meaningfully, and where naproxen holds a clear advantage. The PRECISION trial, the largest randomized safety study ever conducted on these drugs, enrolled over 24,000 arthritis patients and followed them for an average of about 20 months. Cardiovascular events occurred in roughly 2.5% of naproxen patients versus 2.7% of ibuprofen patients.¹² That gap is small, and the trial was designed to test celecoxib rather than to compare the other two head-to-head, but the direction is consistent with a larger body of observational evidence.

A target trial emulation comparing new users of the two drugs found that ibuprofen was associated with roughly an 18% higher rate of major vascular events compared to naproxen, with a notably higher rate of ischemic stroke.¹³ And among patients who had already been hospitalized for serious coronary heart disease, naproxen was the only common NSAID whose use did not raise the risk of another heart event compared to non-use. Ibuprofen, diclofenac, and the older COX-2 inhibitors all carried elevated risk in that population.¹⁴

The mechanism behind naproxen’s relative heart safety is thought to be partly related to its sustained suppression of platelet clumping, a mild blood-thinning effect that is more consistent than ibuprofen’s because of naproxen’s longer presence in the bloodstream. That same platelet effect, however, has consequences for people who take low-dose aspirin for heart protection.

Blood Pressure Effects

Both drugs can raise blood pressure, but ibuprofen appears to do so more aggressively. The PRECISION-ABPM sub-study used 24-hour ambulatory blood pressure monitoring and found that ibuprofen raised average systolic blood pressure by about 3.7 mmHg, naproxen by about 1.6 mmHg, and celecoxib by essentially nothing. Among patients who started with normal blood pressure, about 23% of those on ibuprofen developed hypertension during the trial, compared with 19% on naproxen.¹⁵ If you already have high blood pressure or are on medications to control it, the choice between these two drugs could matter for blood pressure control, and naproxen is the somewhat gentler option.

The Stomach Trade-Off

Naproxen’s advantage for the heart comes at a cost to the stomach. A meta-analysis of individual patient data found that ibuprofen had the lowest risk of serious upper gastrointestinal bleeding among common NSAIDs, while naproxen’s risk was several times higher.¹⁶ A large cohort study comparing the two drugs directly estimated that naproxen carried roughly double the risk of upper GI bleeding within two weeks of a first prescription compared with ibuprofen. The absolute risk with both drugs was low — well under one-tenth of a percent — but the relative difference was consistent.¹⁷

The reason comes back to pharmacokinetics. Because naproxen stays in the body much longer, the stomach lining is exposed to prostaglandin suppression around the clock. Ibuprofen washes out between doses, giving the stomach’s protective mucus layer periodic windows to recover. For someone with a history of ulcers, acid reflux, or GI bleeding, this makes ibuprofen the safer of the two, or at least the less risky. Adding a proton pump inhibitor (a common acid-reducing drug) can offset much of naproxen’s extra stomach risk, and in the PRECISION trial all patients were provided one for exactly this reason.¹⁸

If You Take Low-Dose Aspirin

Millions of people take a daily baby aspirin for heart protection. Both naproxen and ibuprofen can interfere with that aspirin’s ability to prevent blood clots. The problem is competitive: the NSAID and aspirin are trying to reach the same spot on the same enzyme, and if the NSAID gets there first, aspirin cannot do its job. Both ibuprofen and naproxen showed a potent interaction with aspirin in a volunteer study, while celecoxib did not.¹⁹ A crossover study confirmed that both ibuprofen and naproxen pushed aspirin’s clot-preventing effect below the threshold for a meaningful response.²⁰

The usual clinical workaround for ibuprofen is to take the aspirin first and wait at least 30 minutes before taking ibuprofen. Because ibuprofen clears the body quickly, the window of interference is relatively short. Naproxen’s much longer duration means the interference can last most of the day, making timing strategies less practical. If you rely on daily aspirin therapy and need regular NSAID use, this is a conversation worth having with your doctor, because neither drug pairs cleanly with aspirin.

Who Should Pick Which

There is no universal winner, but patterns do emerge based on individual circumstances. Someone with arthritis or chronic back pain who does not have a history of stomach problems and whose main priority is all-day relief with minimal re-dosing is a natural fit for naproxen. Someone who gets sharp, short-lived pain from occasional headaches or sudden cramps, and who has any concern about stomach sensitivity, is better served by ibuprofen’s quicker onset and shorter exposure.

People with heart disease or significant cardiovascular risk factors are generally steered toward naproxen if they need an NSAID at all, because the heart safety data consistently favors it. People with a history of ulcers or GI bleeding are steered the other way, toward ibuprofen or toward adding a stomach-protective drug if naproxen is necessary. People with high blood pressure have another reason to be cautious with ibuprofen specifically, since it raises blood pressure more than naproxen does.

For children, ibuprofen is the standard choice. Its shorter duration makes dosing more predictable and adjustable in smaller bodies, and it has a much longer track record in pediatric use. Naproxen is approved for children over two in some countries but is rarely the first-line recommendation.

During breastfeeding, ibuprofen is considered compatible, with the infant receiving a very small fraction of the mother’s dose.²¹ Naproxen’s longer half-life means it lingers in breast milk for longer, which makes most guidelines favor ibuprofen for nursing mothers. Both drugs should be avoided in the third trimester of pregnancy.

Cost and Accessibility

Both drugs are available over the counter in most countries and are inexpensive. A cost-effectiveness analysis modeling knee osteoarthritis treatment in older patients with multiple health conditions found that adding ibuprofen to standard care was cost-saving, while adding naproxen cost somewhat more but delivered marginally better health outcomes. Using prescription naproxen with a prescription stomach-protective drug pushed costs considerably higher without proportional benefit.²² A separate analysis from the United Arab Emirates found that total per-patient costs were lowest with naproxen but that toxicity-related costs were lowest with celecoxib, reflecting naproxen’s higher GI risk adding downstream healthcare costs.²³

In practical terms, the sticker prices are close enough that cost alone rarely drives the choice. The real financial difference shows up when long-term use requires adding a stomach-protective prescription, at which point the total treatment cost of naproxen can climb well above ibuprofen’s. For occasional, short-term use, price is essentially a non-factor.

Liver Safety and Rare Adverse Effects

Liver injury from either drug is uncommon at recommended doses. In one cohort study comparing low-dose regimens, liver injury occurred in only three patients total across both groups, one on naproxen and two on ibuprofen.²⁴ Neither drug is considered particularly hepatotoxic compared to acetaminophen, which is the painkiller most commonly associated with liver damage when taken in excess. That said, all NSAIDs carry a class warning about potential liver effects, and people with pre-existing liver disease should use either drug cautiously.

Allergic reactions, skin rashes, and kidney effects are possible with both drugs and are class effects rather than distinguishing features between the two. The kidney concern deserves a mention: because naproxen stays in the body longer, the kidneys are exposed to its prostaglandin-suppressing effect more continuously, which could theoretically matter in people with reduced kidney function. In practice, though, neither drug is considered safe for people with significant kidney disease, and the difference between them is less important than the shared risk.